| | | | | |
RNAC Cartesian Therapeutics, Inc. Common Stock | $10,5770 | +5,14% | $317,37M | $46,10K | |
FUND Sprott Focus Trust, Inc. | $10,8790 | +0,64% | $317,19M | $11,91K | |
FATE Fate Therapeutics, Inc. | $2,4750 | +1,43% | $317,04M | $466,26K | |
NMRA Neumora Therapeutics, Inc. Common Stock | $1,5450 | +1,31% | $316,83M | $137,49K | |
GALT Galectin Therapeutics Inc. | $3,9240 | +1,13% | $316,66M | $76,28K | |
NREF NexPoint Real Estate Finance, Inc. | $17,2990 | -1,65% | $316,64M | $12,72K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | $10,8650 | +0,32% | $316,34M | $13,00 | |
PSBD Palmer Square Capital BDC Inc. | $10,2400 | -1,35% | $316,32M | $37,67K | |
| $3,5750 | +14,95% | $316,09M | $1,39M | |
| $6,7100 | +4,36% | $315,88M | $25,17K | |
SMTI Sanara MedTech Inc. Common Stock | $34,3950 | +0,04% | $315,59M | $206,38K | |
MLP Maui Land & Pineapple Co. | $16,0200 | +1,65% | $315,56M | $772,00 | |
AFB Alliance National Municipal Income Fund, Inc. | $10,9250 | -0,05% | $315,33M | $24,54K | |
| $40,8110 | -0,44% | $315,30M | $1,52K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | $10,5350 | +0,04% | $315,30M | $36,28K | |
